癌症护理平台Veris Health完成237万美元私募融资-动脉网

PAVmed, Veris Health finalize private placement financing

MobiHealthNews 等信源发布 2025-02-25 23:44



可切换为仅中文







Photo:

照片：

Matt Lincoln

马特·林肯

/Getty Images

/盖蒂图片社

PAVmed

, a medical technology company focused on devices, diagnostics and digital health, and its subsidiary, cancer care platform

，一家专注于设备、诊断和数字健康的医疗技术公司，及其子公司癌症护理平台

Veris Health

, completed a $2.37 million private placement financing.

，完成了237万美元的私人配售融资。

Accredited investors acquired PAVmed securities priced at-the-market and shares of Veris common stock indicating a pre-money Veris valuation of almost

合格投资者以市价购入了PAVmed证券和Veris普通股，表明Veris的投前估值接近

$35 million.

3500万美元。

The financing augments a recently secured $1.8 million non-dilutive two-year

融资增加了一笔最近获得的180万美元的两年期非稀释性资金

National Institutes of Health (NIH) grant aimed at funding the development of Veris' implantable physiological monitor.

美国国立卫生研究院 (NIH) 拨款，旨在资助 Veris 的可植入生理监测仪的开发。

'This financing marks an important milestone which will allow Veris Health to advance its commercial strategy, including regulatory clearance and launch of its implantable physiological monitor,' Dr. Lishan Aklog, chairman and CEO of PAVmed and executive chairman of Veris Health, said in a statement..

“这笔融资标志着一个重要里程碑，将使Veris Health能够推进其商业战略，包括监管审批和推出其可植入生理监测器，”PAVmed董事长兼首席执行官、Veris Health执行董事长Lishan Aklog博士在一份声明中表示。

'We believe the Veris pre-money valuation reflects strong investor confidence in Veris' long-term commercial potential as it seeks to enhance personalized cancer care through the early detection of complications and reduced unplanned hospitalizations.'

“我们认为，Veris的投前估值反映了投资者对其长期商业潜力的强烈信心，因为它致力于通过早期发现并发症和减少非计划住院来提升个性化癌症护理。”

Aklog added, 'We expect that, once cleared and launched, the implantable monitor will significantly enhance this commercial potential.'

阿克洛格补充说：“我们预计，一旦获得批准并推出，这种可植入监测器将大大增强其商业潜力。”

THE LARGER TREND

更大的趋势

In 2024,

2024年，

Veris Health was awarded a

Veris Health 获得了奖项

$1.8 million grant from the National Institute on Minority Health and Health Disparities

美国国家少数民族健康与健康差异研究所授予的180万美元资助

, part of the NIH. The aim of the two-year grant was to fund research and upgrade and verify the Veris cancer care platform designed for medically underserved patients with cancer.

，是美国国立卫生研究院（NIH）的一部分。这项为期两年的资助旨在为研究提供资金，并升级和验证专为医疗资源不足的癌症患者设计的Veris癌症护理平台。

That same year,

同年，

oncology digital therapeutics company

肿瘤数字治疗公司

Mika Health

米卡健康

and global nonprofit

和全球非营利组织

Cancer Support Community (CSC)

癌症支持社区 (CSC)

announced

宣布

they would jointly provide an AI-enabled oncology-focused digital therapeutic for U.S.-based cancer patients and their caregivers to access mental health and other support services free of charge.

他们将共同为美国的癌症患者及其护理人员提供一种人工智能支持的、专注于肿瘤学的数字治疗方案，以免费获取心理健康和其他支持服务。

Mika provides cancer patients with an app where they can access psychological support to reduce disease-related anxiety, depression and stress. Additionally, patients can also track side effects from medications, receive medication reminders, obtain education and nutrition advice, and coordinate appointments.

米卡为癌症患者提供了一款应用程序，他们可以通过该程序获得心理支持，以减轻与疾病相关的焦虑、抑郁和压力。此外，患者还可以追踪药物的副作用、接收服药提醒、获取教育和营养建议，以及协调预约。

The digital therapeutic, which is already certified as a medical device and released in the EU, can be personalized to an individual's specific type of cancer and will be made available to patients in North America. .

该数字疗法已经被认证为医疗器械并在欧盟发布，可以个性化针对个人的具体癌症类型，并将向北美患者提供。

In 2023,

2023年，

Carrum Health

卡鲁姆健康

, a digital marketplace for employers to purchase bundled healthcare services, partnered with

，一个供雇主购买捆绑式医疗服务的数字市场，与

Florida Cancer Specialists & Research Institute

佛罗里达癌症专家与研究所

to offer employers in Florida breast cancer care services.

为佛罗里达州的雇主提供乳腺癌护理服务。

Carrum offers a value-based platform that allows self-funded employers to buy specialty care, focusing on surgical and cancer care. The platform provides a digital platform that gives patients access to a care specialist who guides them through the surgical process and employers a platform for navigating Carrum's network..

Carrum 提供了一个基于价值的平台，允许自筹资金的雇主购买专科护理，重点关注手术和癌症护理。该平台提供了一个数字平台，患者可以访问护理专家，专家会引导他们完成手术过程，同时为雇主提供一个导航 Carrum 网络的平台。

That same year,

同年，

GE HealthCare

GE医疗

announced a

宣布了一项

collaboration

协作

with Grand Rapids-based cancer treatment center

与位于大急流城的癌症治疗中心

BAMF Health

BAMF健康中心

to advance the adoption of theranostics in the U.S.

推动美国采用治疗诊断学

Theranostics is an emerging technology and a form of precision medicine that fuses imaging technology with therapeutic agents to pinpoint and target cancer cells for destruction.

治疗诊断学是一种新兴技术，也是一种精准医学形式，它将成像技术与治疗剂相结合，以精确定位并靶向摧毁癌细胞。

BAMF Health offers molecular imaging for various types of cancer as well as molecular therapy for patients with prostate and neuroendocrine cancer, with a substantial focus on theranostics. GE HealthCare produces tools that support theranostics, such as cyclotrons, tracer production facility solutions and PET radiochemistry systems, which help BAMF operate its theranostics program. .

BAMF Health 为各种类型的癌症提供分子成像服务，并为前列腺癌和神经内分泌癌患者提供分子治疗，重点关注治疗诊断学。GE HealthCare 生产支持治疗诊断学的工具，例如回旋加速器、示踪剂生产设备解决方案和 PET 放射化学系统，这些工具帮助 BAMF 运营其治疗诊断学项目。

Tags:

标签：

PAVmed

，

Veris Health

，

medical devices

医疗器械

，

digital health

数字健康